Blog Articles
GLP-1 Shortage Prompts Surge of Risky Weight Loss Supplements
July 22, 2024
by Andrea Baker
Despite the high demand for GLP-1 drugs, the cost of these medications is prohibitively expensive for many people. As a result, a slew of merchants are entering the market offering alternative products such as supplements and other healthcare products for weight loss, many of which pose serious health threats to consumers. Weight loss supplements are…
GLP-1 Sales Online: What You Need to Know
July 17, 2024
Recent LegitScript data reveals the skyrocketing promotion of both GLP-1 medications and reported ads associated with selling compounded GLP-1 medications (press release). LegitScript tackles the sale of problematic healthcare products as well as more than 60 other high-risk categories – including counterfeits, weapons, and online gambling – with a multi-pronged approach that employs big data,…
Navigating URL Shifts: Understanding Ownership Changes and Their Impact
July 17, 2024
URL changes are relatively common in the world of e-commerce. Motivations for such changes may be born out of a desire to adapt to organizational shifts such as mergers or rebranding, take advantage of registrar incentives, or sell the domain to an interested party. While the process is often relatively straightforward and involves transferring domain…
What You Need to Know About Medical Spa Risks and Regulations
July 9, 2024
by Cody Haight
Understanding evolving medical spa regulations and requirements is essential for advertisers, business owners, and payment processors.
Key Takeaways: The Challenges of Detecting IP Infringement Online
July 2, 2024
In a recent webinar hosted by LegitScript, Peter Szyszko, CEO of White Bullet, delved into the pressing issue of online IP infringement and how to stop it.
Navigating Marketplace Risk: AI and the ROI of Trust and Safety
June 13, 2024
Trust and safety teams around the world are seeking AI-powered solutions to combat AI-based fraud.
This Is How LegitScript Is Celebrating Pride Month
May 29, 2024
In celebration of Pride Month, LegitScript is waiving fees for addiction treatment providers who serve the LGBTQ+ community.
What You Need to Know About the Different Levels of Merchant Risk
May 21, 2024
Being aware of all three levels of risk and which bucket your merchant falls into is a critical step in quantifying risk.
Navigating Compliance: LegitScript’s Insights from NOCO
May 15, 2024
by Naomi Moono
LegitScript took strides to lead and learn at the Northern Colorado Hemp Exposition (NOCO) — reinforcing our commitment to excellence.
What’s Hiding on Your Marketplace? A Look at How Risk Infiltrates Your Platform
May 8, 2024
You monitor seller listings on your e-commerce marketplace, but do you know what’s going on behind the scenes?
Harnessing Collaboration: Highlights from LegitScript’s First Advisory Committee Meeting of the Year
May 1, 2024
On March 27, 2024, our revitalized Addiction Treatment Certification Advisory Committee convened for the first time.
Emerging Threat: Melanotan, Repackaging, and Online Sales
April 30, 2024
Despite potentially dangerous health effects, a social media trend promoting Melanotan II continues to prevail in the market.
Problematic Product Spotlight: Tianeptine
April 25, 2024
LegitScript has observed a recent rise in both the popularity and regulatory scrutiny of tianeptine, an unregulated substance commonly sold in gas stations and online.
What You Need to Know About CBD Product Labeling Regulations
April 17, 2024
From CBD product labels that claim to prevent disease to truth-in-advertising requirements — LegitScript explores the regulatory environment of CBD.
What You Need to Know About the EU’s Strategy to Combat Counterfeiting
April 9, 2024
This post discusses the strategy, adopted recommendations, and new approaches to stopping the sale of counterfeits in the EU.